סורמונטיל 25 מ"ג Izrael - hebrejčina - Ministry of Health

סורמונטיל 25 מ"ג

sanofi - aventis israel ltd - trimipramine as maleate 25 mg - tablets - trimipramine - antidepressant.

דיפפטיבן Izrael - hebrejčina - Ministry of Health

דיפפטיבן

cure medical & technical supply - l - glutamine; l- alanine - תרכיז להכנת תמיסה לאינפוזיה - l- alanine 8.2 g / 100 ml; l - glutamine 13.46 g / 100 ml - glutamic acid hydrochloride - glutamic acid hydrochloride - dipeptiven is indicated as part of an intravenous parenteral nutrition regimen as a supplement to amino acid solutions or an amino acid containing infusion regimen.in patients in extreme cases of hypercatabolic stage such as major abdominal surgery, bmt, diffuse injury of gi mucous.

אמינופלסמל ב. בראון  % 10 E Izrael - hebrejčina - Ministry of Health

אמינופלסמל ב. בראון % 10 e

lapidot medical import and marketing ltd - arginine; aspartic acid; disodium phosphate dodecahydrate; glutamine; glycine; histidine; isoleucine; l- alanine; leucine; lysine as acetate; magnesium chloride hexahydrate; methionine; phenylalanine; potassium acetate; proline; serine; sodium acetate trihydrate; threonine; tryptophan; tyrosine; valine - תמיסה לאינפוזיה - isoleucine 5.00 g/l; leucine 8.9 g/l; methionine 4.40 g/l; phenylalanine 4.70 g/l; threonine 4.20 g/l; tryptophan 1.60 g/l; valine 6.20 g/l; arginine 11.50 g/l; histidine 3.00 g/l; glycine 12.00 g/l; l- alanine 10.50 g/l; proline 5.50 g/l; aspartic acid 5.60 g/l; glutamine 7.20 g/l; serine 2.30 g/l; tyrosine 0.40 g/l; potassium acetate 2.453 g/l; sodium acetate trihydrate 2.858 g/l; magnesium chloride hexahydrate 0.508 g/l; lysine as acetate 8.56 g/l; disodium phosphate dodecahydrate 3.581 g/l - combinations

אמינופלסמל ב.בראון % 10 Izrael - hebrejčina - Ministry of Health

אמינופלסמל ב.בראון % 10

lapidot medical import and marketing ltd - arginine; aspartic acid; glutamine; glycine; histidine; isoleucine; l- alanine; leucine; lysine as acetate; lysine as monohydrate; methionine; phenylalanine; proline; serine; threonine; tryptophan; tyrosine; valine - תמיסה לאינפוזיה - isoleucine 5.00 g/l; leucine 8.9 g/l; methionine 4.40 g/l; phenylalanine 4.70 g/l; threonine 4.20 g/l; tryptophan 1.60 g/l; valine 6.20 g/l; arginine 11.50 g/l; histidine 3.00 g/l; l- alanine 10.50 g/l; glycine 12.00 g/l; aspartic acid 5.60 g/l; glutamine 7.20 g/l; proline 5.50 g/l; serine 2.30 g/l; tyrosine 0.40 g/l; lysine as acetate 5.74 g/l; lysine as monohydrate 3.12 g/l - combinations

דיפפטיבן Izrael - hebrejčina - Ministry of Health

דיפפטיבן

cure medical & technical supply - l - glutamine; l- alanine - תרכיז להכנת תמיסה לאינפוזיה - l- alanine 8.2 g / 100 ml; l - glutamine 13.46 g / 100 ml - glutamic acid hydrochloride

דיפפטיבן Izrael - hebrejčina - Ministry of Health

דיפפטיבן

cure medical & technical supply - l - glutamine; l- alanine - תרכיז להכנת תמיסה לאינפוזיה - l- alanine 8.2 g / 100 ml; l - glutamine 13.46 g / 100 ml - glutamic acid hydrochloride

T61 וטרינרי Izrael - hebrejčina - Ministry of Health

t61 וטרינרי

intervet ( israel) ltd - embutramide 200 mg/ml; mebezonium 50 mg/ml - solution for injection - for euthanasia of dogs, cats and other animals.

מיקוטיל 300 וטרינרי Izrael - hebrejčina - Ministry of Health

מיקוטיל 300 וטרינרי

euromar ltd - tilmicosin as phosphate - תמיסה להזרקה - tilmicosin as phosphate 300 mg / 1 ml

סטאלבו   10025200 מג Izrael - hebrejčina - Ministry of Health

סטאלבו 10025200 מג

inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 100 mg; carbidopa 25 mg; entacapone 200 mg - levodopa - levodopa - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.

סטאלבו   5012.5200 מג Izrael - hebrejčina - Ministry of Health

סטאלבו 5012.5200 מג

inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 50 mg; carbidopa 12.5 mg; entacapone 200 mg - levodopa and decarboxylase inhibitor - levodopa and decarboxylase inhibitor - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.